Abstract
The frequency of endometrial carcinoma is increasing world-wide, and in most countries in Western Europe and the United States, it is now the most common gynecologic malignancy. In Norway, endometrial carcinoma is the second most common cancer of the female genital tract. Approximately 500 new cases are anticipated in 1991, and about 120 will die of endometrial carcinoma every year in our country. More individualized therapy is probably essential in improving the prognosis for these high-risk patients [1].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Sorbe B., Risberg B., Frankendahl B.: DNA ploidy, morphometry and nuclear grade as prognostic factors in endometrial carcinoma. Gynecol Oncol 38: 22, 1990
Di Saia P.J., Creasman W.T., Boronow R.C., Lessing J.A.: Risk factors and recurrent patterns in stage I endometrial cancer. Amer J Obstet Gynecol 151: 1009, 1985
Iversen O.E.: Flow cytometric deoxyribunucleic acid index: A prognostic factor in endometrial carcinoma. Am J Obstet Gynecol 155: 770, 1986
Lindahl B., Aim O., Fernö M., Killander D., Längström E., Norgren A., Tropé C.: Prognostic value of flow cytometric DNA measurement in stage III endometrial carcinoma: Correlation with steroid receptor concentration, tumor myométrial invasion and degree of differentiation. Anticancer Research 7: 791, 1987
Iversen O.E., Utaker E, Skaarland E.: DNA ploidy and steroid receptors as predictors of disease course in patients with endometrial carcinoma. Acta Obstet Gynecol Scand 67: 531, 1988
Geisinger K.R., Homesley H.D., Torgan T.M., Kute T.E., Marshall R.B.: Endometrial adenocarcinoma: A multiparameter clinico pathological analysis including the DNA profile and the sex steroid hormone receptors. Cancer 58: 1518, 1986
Atkin N.: Prognostic significance of ploidy level in human tumors I carcinoma of the uterus. J Natl Cancer Inst 56: 909, 1976
Moberger B., Auer G., Forslund G., Mogerger G.: The prognostic significance in DNA measurements in endometrial carcinoma. Cytometry 5: 430, 1984
Quillamor R.M., Furlong S.K., Hoschner J.A., Wynn R.M.: Relative prognostic significance of DNA flow cytometry and histologic grading in endometrial carcinoma. Gynecol Obstet Invest 26: 332, 1988
Stendahl U., Wagenius G., Strang P., Tribukait B.: Flow cytometry in invasive endometrial carcinoma. Correlation between DNA content, S-phase rate and clinical parameters. In Vivo 2: 123, 1988
Britton L.C., Wilson T.O., Gaffey T.A., Lieber M.M., Wieland H.S., Podratz K.C.: Flow cytometric DNA analysis of stage I endometrial carcinoma. Gynecol Oncol 34: 317, 1989
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Tropé, C., Kaern, J., Lindahl, B., Vergote, I. (1991). Flow Cytometry in Invasive Endometrial Carcinoma. In: Kleine, W., Meerpohl, HG., Pfleiderer, A., Profous, C.Z. (eds) Therapie des Endometriumkarzinoms. AGO Arbeitsgemeinschaft für Gynäkologische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76950-4_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-76950-4_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-54571-2
Online ISBN: 978-3-642-76950-4
eBook Packages: Springer Book Archive